Product Information
LITHIUM CARBONATE 300 MG CAP is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.0953 per EA under NDC 00054852725. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054852725
Classification
Generic
Dosage Form
CAPSULE, GELATIN COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LITHIUM CARBONATEApproval Type
New Drug (NDA)
FDA Application
NDA017812FDA Approved
Before 1982
TE Code
AB
On Market Since
11/26/1980
Pharmacological Classes
Price Statistics
The NADAC for LITHIUM CARBONATE 300 MG CAP has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 222.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0953 per EA |
|---|---|
| All-time high | $0.1240 (Mar 13, 2024) |
| All-time low | $0.0276 (Nov 18, 2015) |
| 52-week high | $0.1151 |
| 52-week low | $0.0926 |
| Median price | $0.0488 |
| Average price | $0.0565 |
| Largest weekly change | +43.9% (Aug 23, 2023) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LITHIUM CARBONATE 300 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for LITHIUM CARBONATE 300 MG CAP, manufactured by Hikma Pharmaceuticals USA Inc., is $0.0953 per EA (NDC 00054852725), effective Aug 19, 2026.
How has the price of LITHIUM CARBONATE 300 MG CAP changed over time?
Over the history we have for it, the NADAC for LITHIUM CARBONATE 300 MG CAP has risen 222.9%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LITHIUM CARBONATE 300 MG CAP?
Since Nov 28, 2013, the NADAC for LITHIUM CARBONATE 300 MG CAP has ranged from a low of $0.0276 (Nov 18, 2015) to a high of $0.1240 (Mar 13, 2024), with a median of $0.0488 per EA.
Are there cheaper alternatives to LITHIUM CARBONATE 300 MG CAP?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LITHIUM CARBONATE 300 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures LITHIUM CARBONATE 300 MG CAP?
LITHIUM CARBONATE 300 MG CAP (NDC 00054852725) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.